Table of Contents 1 Market Overview of COVID-19 Molecular Diagnostics 1.1 COVID-19 Molecular Diagnostics Market Overview 1.1.1 COVID-19 Molecular Diagnostics Product Scope 1.1.2 COVID-19 Molecular Diagnostics Market Status and Outlook 1.2 Global COVID-19 Molecular Diagnostics Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global COVID-19 Molecular Diagnostics Market Size by Region (2016-2027) 1.4 Global COVID-19 Molecular Diagnostics Historic Market Size by Region (2016-2021) 1.5 Global COVID-19 Molecular Diagnostics Market Size Forecast by Region (2022-2027) 1.6 Key Regions, COVID-19 Molecular Diagnostics Market Size (2016-2027) 1.6.1 North America COVID-19 Molecular Diagnostics Market Size (2016-2027) 1.6.2 Europe COVID-19 Molecular Diagnostics Market Size (2016-2027) 1.6.3 Asia-Pacific COVID-19 Molecular Diagnostics Market Size (2016-2027) 1.6.4 Latin America COVID-19 Molecular Diagnostics Market Size (2016-2027) 1.6.5 Middle East & Africa COVID-19 Molecular Diagnostics Market Size (2016-2027) 2 COVID-19 Molecular Diagnostics Market Overview by Type 2.1 Global COVID-19 Molecular Diagnostics Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global COVID-19 Molecular Diagnostics Historic Market Size by Type (2016-2021) 2.3 Global COVID-19 Molecular Diagnostics Forecasted Market Size by Type (2022-2027) 2.4 High-throughput Sequencing 2.5 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR 2.6 Immunological Detection 3 COVID-19 Molecular Diagnostics Market Overview by Application 3.1 Global COVID-19 Molecular Diagnostics Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global COVID-19 Molecular Diagnostics Historic Market Size by Application (2016-2021) 3.3 Global COVID-19 Molecular Diagnostics Forecasted Market Size by Application (2022-2027) 3.4 Hospitals 3.5 Scientific Research 3.6 Biodiagnostics 4 COVID-19 Molecular Diagnostics Competition Analysis by Players 4.1 Global COVID-19 Molecular Diagnostics Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2020) 4.3 Date of Key Players Enter into COVID-19 Molecular Diagnostics Market 4.4 Global Top Players COVID-19 Molecular Diagnostics Headquarters and Area Served 4.5 Key Players COVID-19 Molecular Diagnostics Product Solution and Service 4.6 Competitive Status 4.6.1 COVID-19 Molecular Diagnostics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Cellex 5.1.1 Cellex Profile 5.1.2 Cellex Main Business 5.1.3 Cellex COVID-19 Molecular Diagnostics Products, Services and Solutions 5.1.4 Cellex COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.1.5 Cellex Recent Developments 5.2 Abbott 5.2.1 Abbott Profile 5.2.2 Abbott Main Business 5.2.3 Abbott COVID-19 Molecular Diagnostics Products, Services and Solutions 5.2.4 Abbott COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.2.5 Abbott Recent Developments 5.3 Roche 5.5.1 Roche Profile 5.3.2 Roche Main Business 5.3.3 Roche COVID-19 Molecular Diagnostics Products, Services and Solutions 5.3.4 Roche COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.3.5 BioMedomics Recent Developments 5.4 BioMedomics 5.4.1 BioMedomics Profile 5.4.2 BioMedomics Main Business 5.4.3 BioMedomics COVID-19 Molecular Diagnostics Products, Services and Solutions 5.4.4 BioMedomics COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.4.5 BioMedomics Recent Developments 5.5 BD 5.5.1 BD Profile 5.5.2 BD Main Business 5.5.3 BD COVID-19 Molecular Diagnostics Products, Services and Solutions 5.5.4 BD COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.5.5 BD Recent Developments 5.6 Henry Schein 5.6.1 Henry Schein Profile 5.6.2 Henry Schein Main Business 5.6.3 Henry Schein COVID-19 Molecular Diagnostics Products, Services and Solutions 5.6.4 Henry Schein COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.6.5 Henry Schein Recent Developments 5.7 Safecare Bio-Tech 5.7.1 Safecare Bio-Tech Profile 5.7.2 Safecare Bio-Tech Main Business 5.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions 5.7.4 Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.7.5 Safecare Bio-Tech Recent Developments 5.8 Thermo Fisher 5.8.1 Thermo Fisher Profile 5.8.2 Thermo Fisher Main Business 5.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Products, Services and Solutions 5.8.4 Thermo Fisher COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.8.5 Thermo Fisher Recent Developments 5.9 Bio-rad 5.9.1 Bio-rad Profile 5.9.2 Bio-rad Main Business 5.9.3 Bio-rad COVID-19 Molecular Diagnostics Products, Services and Solutions 5.9.4 Bio-rad COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.9.5 Bio-rad Recent Developments 5.10 Agilent 5.10.1 Agilent Profile 5.10.2 Agilent Main Business 5.10.3 Agilent COVID-19 Molecular Diagnostics Products, Services and Solutions 5.10.4 Agilent COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.10.5 Agilent Recent Developments 5.11 Ortho Clinical Diagnostics 5.11.1 Ortho Clinical Diagnostics Profile 5.11.2 Ortho Clinical Diagnostics Main Business 5.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions 5.11.4 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.11.5 Ortho Clinical Diagnostics Recent Developments 5.12 Zhejiang Orient Gene Biotech 5.12.1 Zhejiang Orient Gene Biotech Profile 5.12.2 Zhejiang Orient Gene Biotech Main Business 5.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions 5.12.4 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.12.5 Zhejiang Orient Gene Biotech Recent Developments 5.13 Innovita Biological Technology 5.13.1 Innovita Biological Technology Profile 5.13.2 Innovita Biological Technology Main Business 5.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Products, Services and Solutions 5.13.4 Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.13.5 Innovita Biological Technology Recent Developments 5.14 Guangzhou Wondfo Biotech 5.14.1 Guangzhou Wondfo Biotech Profile 5.14.2 Guangzhou Wondfo Biotech Main Business 5.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions 5.14.4 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.14.5 Guangzhou Wondfo Biotech Recent Developments 5.15 Guangdong Hecin-Scientific 5.15.1 Guangdong Hecin-Scientific Profile 5.15.2 Guangdong Hecin-Scientific Main Business 5.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Products, Services and Solutions 5.15.4 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.15.5 Guangdong Hecin-Scientific Recent Developments 5.16 Dynamiker Biotechnology (Tianjin) 5.16.1 Dynamiker Biotechnology (Tianjin) Profile 5.16.2 Dynamiker Biotechnology (Tianjin) Main Business 5.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Products, Services and Solutions 5.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments 5.17 ADVAITE 5.17.1 ADVAITE Profile 5.17.2 ADVAITE Main Business 5.17.3 ADVAITE COVID-19 Molecular Diagnostics Products, Services and Solutions 5.17.4 ADVAITE COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.17.5 ADVAITE Recent Developments 5.18 Mayo Clinic Laboratories 5.18.1 Mayo Clinic Laboratories Profile 5.18.2 Mayo Clinic Laboratories Main Business 5.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Products, Services and Solutions 5.18.4 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.18.5 Mayo Clinic Laboratories Recent Developments 5.19 Chembio Diagnostics 5.19.1 Chembio Diagnostics Profile 5.19.2 Chembio Diagnostics Main Business 5.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions 5.19.4 Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.19.5 Chembio Diagnostics Recent Developments 5.20 Mount Sinai Laboratory 5.20.1 Mount Sinai Laboratory Profile 5.20.2 Mount Sinai Laboratory Main Business 5.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Products, Services and Solutions 5.20.4 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.20.5 Mount Sinai Laboratory Recent Developments 5.21 QIAGEN 5.21.1 QIAGEN Profile 5.21.2 QIAGEN Main Business 5.21.3 QIAGEN COVID-19 Molecular Diagnostics Products, Services and Solutions 5.21.4 QIAGEN COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.21.5 QIAGEN Recent Developments 5.22 Bioer 5.22.1 Bioer Profile 5.22.2 Bioer Main Business 5.22.3 Bioer COVID-19 Molecular Diagnostics Products, Services and Solutions 5.22.4 Bioer COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.22.5 Bioer Recent Developments 5.23 Biosynex 5.23.1 Biosynex Profile 5.23.2 Biosynex Main Business 5.23.3 Biosynex COVID-19 Molecular Diagnostics Products, Services and Solutions 5.23.4 Biosynex COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.23.5 Biosynex Recent Developments 5.24 Esco 5.24.1 Esco Profile 5.24.2 Esco Main Business 5.24.3 Esco COVID-19 Molecular Diagnostics Products, Services and Solutions 5.24.4 Esco COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.24.5 Esco Recent Developments 5.25 Analytik Jena 5.25.1 Analytik Jena Profile 5.25.2 Analytik Jena Main Business 5.25.3 Analytik Jena COVID-19 Molecular Diagnostics Products, Services and Solutions 5.25.4 Analytik Jena COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.25.5 Analytik Jena Recent Developments 5.26 Techne 5.26.1 Techne Profile 5.26.2 Techne Main Business 5.26.3 Techne COVID-19 Molecular Diagnostics Products, Services and Solutions 5.26.4 Techne COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.26.5 Techne Recent Developments 5.27 Da An Gene 5.27.1 Da An Gene Profile 5.27.2 Da An Gene Main Business 5.27.3 Da An Gene COVID-19 Molecular Diagnostics Products, Services and Solutions 5.27.4 Da An Gene COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.27.5 Da An Gene Recent Developments 5.28 BGI 5.28.1 BGI Profile 5.28.2 BGI Main Business 5.28.3 BGI COVID-19 Molecular Diagnostics Products, Services and Solutions 5.28.4 BGI COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.28.5 BGI Recent Developments 5.29 Shanghai ZJ Bio-Tech 5.29.1 Shanghai ZJ Bio-Tech Profile 5.29.2 Shanghai ZJ Bio-Tech Main Business 5.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions 5.29.4 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2016-2021) 5.29.5 Shanghai ZJ Bio-Tech Recent Developments 6 North America 6.1 North America COVID-19 Molecular Diagnostics Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe COVID-19 Molecular Diagnostics Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America COVID-19 Molecular Diagnostics Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 COVID-19 Molecular Diagnostics Market Dynamics 11.1 COVID-19 Molecular Diagnostics Industry Trends 11.2 COVID-19 Molecular Diagnostics Market Drivers 11.3 COVID-19 Molecular Diagnostics Market Challenges 11.4 COVID-19 Molecular Diagnostics Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market COVID-19 Molecular Diagnostics Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global COVID-19 Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 3. Global COVID-19 Molecular Diagnostics Market Size Share by Region (2016-2021) Table 4. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global COVID-19 Molecular Diagnostics Forecasted Market Size Share by Region (2022-2027) Table 6. Global COVID-19 Molecular Diagnostics Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global COVID-19 Molecular Diagnostics Market Size by Type (2016-2021) & (US$ Million) Table 8. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type (2016-2021) Table 9. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type (2022-2027) Table 11. Global COVID-19 Molecular Diagnostics Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global COVID-19 Molecular Diagnostics Market Size by Application (2016-2021) & (US$ Million) Table 13. Global COVID-19 Molecular Diagnostics Revenue Market Share by Application (2016-2021) Table 14. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global COVID-19 Molecular Diagnostics Revenue Market Share by Application (2022-2027) Table 16. Global COVID-19 Molecular Diagnostics Revenue (US$ Million) by Players (2016-2021) Table 17. Global COVID-19 Molecular Diagnostics Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2020) Table 19. Date of Key Manufacturers Enter into COVID-19 Molecular Diagnostics Market Table 20. Global COVID-19 Molecular Diagnostics Top Players Headquarters and Area Served Table 21. COVID-19 Molecular Diagnostics Product Solution and Service Table 22. Global COVID-19 Molecular Diagnostics Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Cellex Basic Information List Table 25. Cellex Description and Business Overview Table 26. Cellex COVID-19 Molecular Diagnostics Products, Services and Solutions Table 27. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Cellex (2016-2021) Table 28. Cellex Recent Developments Table 29. Abbott Basic Information List Table 30. Abbott Description and Business Overview Table 31. Abbott COVID-19 Molecular Diagnostics Products, Services and Solutions Table 32. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Abbott (2016-2021) Table 33. Abbott Recent Developments Table 34. Roche Basic Information List Table 35. Roche Description and Business Overview Table 36. Roche COVID-19 Molecular Diagnostics Products, Services and Solutions Table 37. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Roche (2016-2021) Table 38. Roche Recent Developments Table 39. BioMedomics Basic Information List Table 40. BioMedomics Description and Business Overview Table 41. BioMedomics COVID-19 Molecular Diagnostics Products, Services and Solutions Table 42. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BioMedomics (2016-2021) Table 43. BioMedomics Recent Developments Table 44. BD Basic Information List Table 45. BD Description and Business Overview Table 46. BD COVID-19 Molecular Diagnostics Products, Services and Solutions Table 47. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BD (2016-2021) Table 48. BD Recent Developments Table 49. Henry Schein Basic Information List Table 50. Henry Schein Description and Business Overview Table 51. Henry Schein COVID-19 Molecular Diagnostics Products, Services and Solutions Table 52. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Henry Schein (2016-2021) Table 53. Henry Schein Recent Developments Table 54. Safecare Bio-Tech Basic Information List Table 55. Safecare Bio-Tech Description and Business Overview Table 56. Safecare Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions Table 57. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Safecare Bio-Tech (2016-2021) Table 58. Safecare Bio-Tech Recent Developments Table 59. Thermo Fisher Basic Information List Table 60. Thermo Fisher Description and Business Overview Table 61. Thermo Fisher COVID-19 Molecular Diagnostics Products, Services and Solutions Table 62. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Thermo Fisher (2016-2021) Table 63. Thermo Fisher Recent Developments Table 64. Bio-rad Basic Information List Table 65. Bio-rad Description and Business Overview Table 66. Bio-rad COVID-19 Molecular Diagnostics Products, Services and Solutions Table 67. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Bio-rad (2016-2021) Table 68. Bio-rad Recent Developments Table 69. Agilent Basic Information List Table 70. Agilent Description and Business Overview Table 71. Agilent COVID-19 Molecular Diagnostics Products, Services and Solutions Table 72. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Agilent (2016-2021) Table 73. Agilent Recent Developments Table 74. Ortho Clinical Diagnostics Basic Information List Table 75. Ortho Clinical Diagnostics Description and Business Overview Table 76. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions Table 77. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Ortho Clinical Diagnostics (2016-2021) Table 78. Ortho Clinical Diagnostics Recent Developments Table 79. Zhejiang Orient Gene Biotech Basic Information List Table 80. Zhejiang Orient Gene Biotech Description and Business Overview Table 81. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions Table 82. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Zhejiang Orient Gene Biotech (2016-2021) Table 83. Zhejiang Orient Gene Biotech Recent Developments Table 84. Innovita Biological Technology Basic Information List Table 85. Innovita Biological Technology Description and Business Overview Table 86. Innovita Biological Technology COVID-19 Molecular Diagnostics Products, Services and Solutions Table 87. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Innovita Biological Technology (2016-2021) Table 88. Innovita Biological Technology Recent Developments Table 89. Guangzhou Wondfo Biotech Basic Information List Table 90. Guangzhou Wondfo Biotech Description and Business Overview Table 91. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions Table 92. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Guangzhou Wondfo Biotech (2016-2021) Table 93. Guangzhou Wondfo Biotech Recent Developments Table 94. Guangdong Hecin-Scientific Basic Information List Table 95. Guangdong Hecin-Scientific Description and Business Overview Table 96. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Products, Services and Solutions Table 97. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Guangdong Hecin-Scientific (2016-2021) Table 98. Guangdong Hecin-Scientific Recent Developments Table 99. Dynamiker Biotechnology (Tianjin) Basic Information List Table 100. Dynamiker Biotechnology (Tianjin) Description and Business Overview Table 101. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Products, Services and Solutions Table 102. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Dynamiker Biotechnology (Tianjin) (2016-2021) Table 103. Dynamiker Biotechnology (Tianjin) Recent Developments Table 104. ADVAITE Basic Information List Table 105. ADVAITE Description and Business Overview Table 106. ADVAITE COVID-19 Molecular Diagnostics Products, Services and Solutions Table 107. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of ADVAITE (2016-2021) Table 108. ADVAITE Recent Developments Table 109. Mayo Clinic Laboratories Basic Information List Table 110. Mayo Clinic Laboratories Description and Business Overview Table 111. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Products, Services and Solutions Table 112. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Mayo Clinic Laboratories (2016-2021) Table 113. Mayo Clinic Laboratories Recent Developments Table 114. Chembio Diagnostics Basic Information List Table 115. Chembio Diagnostics Description and Business Overview Table 116. Chembio Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions Table 117. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Chembio Diagnostics (2016-2021) Table 118. Chembio Diagnostics Recent Developments Table 119. Mount Sinai Laboratory Basic Information List Table 120. Mount Sinai Laboratory Description and Business Overview Table 121. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Products, Services and Solutions Table 122. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Mount Sinai Laboratory (2016-2021) Table 123. Mount Sinai Laboratory Recent Developments Table 124. QIAGEN Basic Information List Table 125. QIAGEN Description and Business Overview Table 126. QIAGEN COVID-19 Molecular Diagnostics Products, Services and Solutions Table 127. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of QIAGEN (2016-2021) Table 128. QIAGEN Recent Developments Table 129. Bioer Basic Information List Table 130. Bioer Description and Business Overview Table 131. Bioer COVID-19 Molecular Diagnostics Products, Services and Solutions Table 132. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Bioer (2016-2021) Table 133. Bioer Recent Developments Table 134. Biosynex Basic Information List Table 135. Biosynex Description and Business Overview Table 136. Biosynex COVID-19 Molecular Diagnostics Products, Services and Solutions Table 137. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Biosynex (2016-2021) Table 138. Biosynex Recent Developments Table 139. Esco Basic Information List Table 140. Esco Description and Business Overview Table 141. Esco COVID-19 Molecular Diagnostics Products, Services and Solutions Table 142. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Esco (2016-2021) Table 143. Esco Recent Developments Table 144. Analytik Jena Basic Information List Table 145. Analytik Jena Description and Business Overview Table 146. Analytik Jena COVID-19 Molecular Diagnostics Products, Services and Solutions Table 147. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Analytik Jena (2016-2021) Table 148. Analytik Jena Recent Developments Table 149. Techne Basic Information List Table 150. Techne Description and Business Overview Table 151. Techne COVID-19 Molecular Diagnostics Products, Services and Solutions Table 152. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Techne (2016-2021) Table 153. Techne Recent Developments Table 154. Da An Gene Basic Information List Table 155. Da An Gene Description and Business Overview Table 156. Da An Gene COVID-19 Molecular Diagnostics Products, Services and Solutions Table 157. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Da An Gene (2016-2021) Table 158. Da An Gene Recent Developments Table 159. BGI Basic Information List Table 160. BGI Description and Business Overview Table 161. BGI COVID-19 Molecular Diagnostics Products, Services and Solutions Table 162. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BGI (2016-2021) Table 163. BGI Recent Developments Table 164. Shanghai ZJ Bio-Tech Basic Information List Table 165. Shanghai ZJ Bio-Tech Description and Business Overview Table 166. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions Table 167. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Shanghai ZJ Bio-Tech (2016-2021) Table 168. Shanghai ZJ Bio-Tech Recent Developments Table 169. North America COVID-19 Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 170. North America COVID-19 Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 171. Europe COVID-19 Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 172. Europe COVID-19 Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 173. Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 174. Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million) Table 175. Asia-Pacific COVID-19 Molecular Diagnostics Market Share by Region (2016-2021) Table 176. Asia-Pacific COVID-19 Molecular Diagnostics Market Share by Region (2022-2027) Table 177. Latin America COVID-19 Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 178. Latin America COVID-19 Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 179. Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Players (2016-2021) & (US$ Million) Table 180. Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 181. COVID-19 Molecular Diagnostics Market Trends Table 182. COVID-19 Molecular Diagnostics Market Drivers Table 183. COVID-19 Molecular Diagnostics Market Challenges Table 184. COVID-19 Molecular Diagnostics Market Restraints Table 185. Research Programs/Design for This Report Table 186. Key Data Information from Secondary Sources Table 187. Key Data Information from Primary Sources List of Figures Figure 1. Global COVID-19 Molecular Diagnostics Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global COVID-19 Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global COVID-19 Molecular Diagnostics Market Share by Regions: 2021 VS 2027 Figure 4. Global COVID-19 Molecular Diagnostics Forecasted Market Size Share by Region (2022-2027) Figure 5. North America COVID-19 Molecular Diagnostics Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe COVID-19 Molecular Diagnostics Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific COVID-19 Molecular Diagnostics Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America COVID-19 Molecular Diagnostics Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa COVID-19 Molecular Diagnostics Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global COVID-19 Molecular Diagnostics Market Size Share by Type in 2021 & 2027 Figure 11. High-throughput Sequencing Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Immunological Detection Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global COVID-19 Molecular Diagnostics Market Size Share by Application in 2021 & 2027 Figure 15. Hospitals Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Scientific Research Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Biodiagnostics Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Top 5 and Top 10 Players COVID-19 Molecular Diagnostics Market Share in 2020 Figure 20. North America COVID-19 Molecular Diagnostics Market Share by Country (2016-2027) Figure 21. United States COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 22. Canada COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 23. Germany COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 24. France COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 25. U.K. COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 26. Italy COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 27. Russia COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 28. Nordic COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 29. Rest of Europe COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 30. Asia-Pacific COVID-19 Molecular Diagnostics Market Share by Region (2016-2027) Figure 31. China COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 32. Japan COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 33. South Korea COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 34. Southeast Asia COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 35. India COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 36. Australia COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 37. Rest of Asia-Pacific COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 38. Latin America COVID-19 Molecular Diagnostics Market Share by Country (2016-2027) Figure 39. Mexico COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 40. Brazil COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Latin America COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 42. Middle East & Africa COVID-19 Molecular Diagnostics Market Share by Country (2016-2027) Figure 43. Turkey COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 44. Saudi Arabia COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 45. UAE COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Middle East & Africa COVID-19 Molecular Diagnostics Market Size (2016-2027) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Cellex Abbott Roche BioMedomics BD Henry Schein Safecare Bio-Tech Thermo Fisher Bio-rad Agilent Ortho Clinical Diagnostics Zhejiang Orient Gene Biotech Innovita Biological Technology Guangzhou Wondfo Biotech Guangdong Hecin-Scientific Dynamiker Biotechnology (Tianjin) ADVAITE Mayo Clinic Laboratories Chembio Diagnostics Mount Sinai Laboratory QIAGEN Bioer Biosynex Esco Analytik Jena Techne Da An Gene BGI Shanghai ZJ Bio-Tech